A detailed history of Grey Street Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Grey Street Capital, LLC holds 130,954 shares of TEVA stock, worth $2.24 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
130,954
Previous 131,000 0.04%
Holding current value
$2.24 Million
Previous $1.37 Billion 35.11%
% of portfolio
0.25%
Previous 0.65%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

SELL
$10.67 - $14.43 $490 - $663
-46 Reduced 0.04%
130,954 $1.85 Billion
Q1 2023

May 10, 2023

BUY
$8.36 - $11.37 $1.1 Million - $1.49 Million
131,000 New
131,000 $1.16 Billion

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.